Jul

28

2025

Isolated Elevation in Prothrombin Time (PT)

By William Aird

Strictly speaking, an isolated elevation in prothrombin time (PT) with normal activated partial thromboplastin time (aPTT) reflects a defect in the extrinsic pathway, and factor VII deficiency is the only true isolated cause.

Core Principle:

  • PT measures: Factors I (fibrinogen), II (prothrombin), V, VII, and X
  • aPTT measures: Factors I, II, V, VIII, IX, X, XI, XII
  • Only factor VII is exclusive to the PT (extrinsic) pathway

It follows that:

  • Isolated PT prolongation = Factor VII abnormality (either deficiency or inhibition).

Practically speaking, a prolonged PT with normal aPTT may also result from::

  • Early vitamin K deficiency
    • Factor VII is first to fall due to its short half-life
  • Warfarin therapy (early)
    • Depletes factor VII faster than others
  • Liver disease
    • Factor VIII is not made in the liver; it’s produced by endothelial cells
    • In advanced liver disease, FVIII levels may remain normal or rise (due to inflammation or endothelial activation)
    • So while PT (sensitive to FVII and the common pathway) prolongs, aPTT may be less affected or normal because elevated FVIII counteracts deficiencies in other intrinsic pathway factors (like IX, XI)
  • Disseminated intravascular coagulation:
    • Consumption of multiple clotting factors → prolongs both PT and aPTT
    • BUT FVIII is an acute-phase reactant → levels can be elevated in early or compensated DIC
    • This may mask aPTT prolongation (by masking deficiencies in other intrinsic pathway factors), making it appear disproportionately normal compared to the PT

A single-institution retrospective study of causes of prolonged prothrombin time and activated partial thromboplastin time in the outpatient setting” (Hazim et al., Int J Lab Hematol, 2022)

  • Isolated Prolonged PT (with normal aPTT):
    • Total patients: 27 out of 77 (35% of those with persistent abnormalities)
    • Acquired causes (22% of total cohort):
      • Vitamin K deficiency – 8 patients
      • Liver disease (affecting factor VII synthesis) – 4 patients
      • Anticoagulation therapy effect – 4 patients (likely warfarin)
      • Multiple factor deficiency (e.g., myelodysplastic syndrome) – 1 patient
    • Congenital causes (13% of total cohort):
      • Factor VII deficiency – 9 patients
      • Factor V deficiency – 1 patient
  • Clinical pearls:
    • Vitamin K deficiency was the most common acquired cause of isolated PT prolongation.
    • Factor VII deficiency was the most common congenital cause, consistent with the understanding that PT is exclusively sensitive to FVII.
    • Mild liver disease may present with isolated PT prolongation due to the short half-life of FVII.
    • Mixing studies were not routinely performed for mild PT prolongation (<14 s) because they nearly always corrected.